Innovent Biologics Inc. (IVBXF)
OTC: IVBXF
· Real-Time Price · USD
12.72
0.34 (2.75%)
At close: Oct 03, 2025, 1:56 PM
Innovent Biologics Income Statement
Financials in CNY. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 |
| Period Ending | Jun 30, 2025 | Dec 31, 2024 | Jun 30, 2024 | Dec 31, 2023 | Jun 30, 2023 | Dec 31, 2022 | Jun 30, 2022 | Dec 31, 2021 | Jun 30, 2021 |
Revenue | 11.42B | 9.42B | 7.46B | 6.21B | 5.02B | 4.56B | 4.57B | 4.27B | 4.8B |
Cost of Revenue | 2.67B | 2.41B | 2.12B | 1.81B | 1.46B | 1.38B | 1.38B | 1.22B | 1.01B |
Gross Profit | 8.75B | 7.01B | 5.34B | 4.4B | 3.56B | 3.17B | 3.19B | 3.05B | 3.79B |
Operating Income | 758.37M | -755.87M | -1.7B | -1.68B | -2.39B | -3.12B | -3.17B | -2.7B | -761.58M |
Interest Income | n/a | n/a | 402.55M | 452.84M | 182.7M | 132.41M | 142.8M | 142.8M | 95.44M |
Pretax Income | 1.21B | -78.62M | -1.28B | -1.14B | -1.43B | -2.17B | -2.64B | -2.64B | -1.26B |
Net Income | 1.13B | -94.63M | -1.28B | -1.03B | -1.37B | -2.18B | -2.68B | -2.73B | -1.39B |
Selling & General & Admin | 5.7B | 5.08B | 4.33B | 3.85B | 3.34B | 3.43B | 3.84B | 3.43B | 2.54B |
Research & Development | 2.29B | 2.68B | 2.7B | 2.23B | 2.62B | 2.87B | 2.52B | 2.32B | 2.02B |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 7.99B | 7.77B | 7.04B | 5.57B | 5.07B | 5.43B | 5.9B | 5.78B | 5.1B |
Interest Expense | n/a | n/a | n/a | n/a | n/a | 44.57M | 157.07M | 139.61M | 27.1M |
Selling & Marketing Expenses | 4.84B | 4.35B | 3.63B | 3.1B | 2.54B | 2.59B | 2.93B | 2.62B | 1.98B |
Cost & Expenses | 10.66B | 10.18B | 9.16B | 7.37B | 6.53B | 6.81B | 7.28B | 7B | 6.11B |
Income Tax Expense | 78.77M | 16.01M | 497K | 117.42M | 174.21M | 105.69M | 135.33M | 87.04M | 136.33M |
Shares Outstanding (Basic) | 1.7B | 1.67B | 1.62B | 1.58B | 1.54B | 1.52B | 1.46B | 1.45B | 1.45B |
Shares Outstanding (Diluted) | 1.69B | 1.63B | 1.62B | 1.58B | 1.54B | 1.52B | 1.47B | 1.46B | 1.45B |
EPS (Basic) | 0.69 | -0.06 | -0.8 | -0.65 | -0.91 | -1.46 | -1.82 | -1.88 | -0.98 |
EPS (Diluted) | 0.67 | -0.06 | -0.8 | -0.65 | -0.91 | -1.46 | -1.82 | -1.88 | -0.98 |
EBITDA | 798.16M | -480.28M | -990.62M | -1.29B | -2.08B | -2.88B | -2.98B | -2.54B | -663.59M |
EBIT | 450M | -755.87M | -1.28B | -1.56B | -2.39B | -3.12B | -3.17B | -2.7B | -761.58M |
Depreciation & Amortization | 348.17M | 275.6M | 286.8M | 275.6M | 312.14M | 245.09M | 192.89M | 165.4M | 97.99M |